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An automated monosegmented flow analyser containing a
sampling valve and a reagent addition module and
employing a laboratory-made photodiode array
spectrophotometer as detection system is described. The
instrument was controlled by a 386SX IBM compatible
microcomputer through an IC8255 parallel port that
communicates with the interface which controls the
sampling valve and reagent addition module. The
spectrophotometer was controlled by the same
microcomputer through an RS232 serial standard
interface. The software for the instrument was written in
QuickBasic 4.5. Opto-switches were employed to detect
the air bubbles limiting the monosegment, allowing
precise sample localisation for reagent addition and signal
reading. The main characteristics of the analyser are low
reagent consumption and high sensitivity which is
independent of the sample volume. The instrument was
designed to determine glucose, creatinine or urea in blood
plasma and serum without hardware modification. The
results were compared against those obtained by the
Clinical Hospital of UNICAMP using commercial
analysers. Correlation coefficients among the methods
were 0.997, 0.982 and 0.996 for glucose, creatinine and
urea, respectively.
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Automatic analysers are being widely used nowadays owing to
the demand for high turnover determinations, mainly in the
clinical and environmental fields. These analysers give precise
and accurate results with low consumption of both reagents and
sample, allowing high laboratory productivity.
Analysers can be divided into three categories according to
the sample processing method: robotic, batch (or discrete) and
continuous analysers.1,2 Robot based and batch automatic
analysers need high precision mechanical parts and, therefore,
are very difficult to maintain by small routine laboratories. On
the other hand, continuous flow systems, such as flow injection
(FI) and continuous flow analysis (CFA),3 are simple and an
automatic flow instrument can be easily implemented.
Automatic flow analysers employing the FI technique have
recently been described.4–10 The construction of this kind of
analyser is relatively simple because samples are individually
processed by these systems, that is, the software to control the
instrument has to perform a number of sequential operations
without any parallel processing because usually only one
sample is processed in the manifold each time.
Monosegmented flow analysis (MSFA)3 was proposed by
Pasquini and de Oliveira11 in 1985. In the MSFA system, the
sample (previously mixed with reagents) is introduced into the
analyser between two air bubbles. These bubbles minimise
sample dispersion, allowing long residence times. The sampling
frequency can be maintained as high as in FI systems with
several samples simultaneously present in the reaction coil;
therefore, there is no direct relationship between sample
injection and sample detection. Two main approaches have
been taken to add and mix reagents for the samples. The first,
which was proposed in the original paper11 and has since been
frequently used,12–15 employs differential pumping to mix
reagents with the sample, before filling the sample loop. The
second uses continuous addition of reagents through a con-
fluence point after injection.16–18 The first procedure does not
allow methods based on sequential reactions to be adapted to
MSFA systems such as the determination of urea by employing
urease enzymatic hydrolysis followed by the Berthelot reaction
for ammonium determination. The second, in addition to the
high reagent consumption, destroys the integrity of the
monosegment and is only feasible when the air bubbles are
either removed before sample detection16 or do not cause
spurious signals in the detector, as when AAS is employed.17,18
Air bubble removal has often been employed before the sample
reaches the detector.11–15,19 This operation eliminates spurious
signals but increases sample dispersion. However, Facchin and
Pasquini20 have recently described monosegmented flow sys-
tems which perform liquid–liquid extractions, showing that it is
possible to carry out the determination without removal of air
bubbles.
This paper describes the construction of a microcomputer
controlled automatic monosegmented flow analyser which has
three main components: a sampling valve, a reagent addition
module and a detection system with a photodiode array
spectrophotometer.21 Opto-switches were employed to detect
the air bubbles limiting the monosegment, allowing sample
localisation for reagent addition and for detection.
The analyser was applied to the determination of glucose,
creatinine and urea in blood plasma and serum by employing the
well established GOD–PAP, Jaffé reaction and urease–Berthe-
lot methods, respectively. The manifold was designed to allow
the determination of each of these analytes with only minor
changes. These three analytes were chosen because they are
often required in clinical tests; for example, they represent about
40% of the whole demand for analyses at the Clinical Hospital
of UNICAMP.
Experimental
Fig. 1 shows a simplified diagram of the analyser. The
instrument was controlled by a 386SX IBM compatible
microcomputer (25 MHz, 2 Mbytes RAM) through an IC 8255
parallel port22 that communicates with an interface which uses
an address decoder similar to one described elsewhere.23 The
interface controls the peristaltic pump on–off state and the
sampling valve. Sample localisation and sampling valve
position were followed by employing opto-switches that
generate TTL signals which can be accessed by the microcom-
puter as described previously.24 A laboratory-made diode array
spectrophotometer21 was used as a detector and was controlled
by the microcomputer through an RS232 serial interface.
Automatic Sampling Valve
The sampling valve was constructed by employing a propor-
tional injector25 whose sliding central bar was connected to a
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stepper motor (24 V, 1 A, 7.5° per step). The sampling and
injection positions of the valve were determined by using two
PCST 2103 opto-switches (optos S and I in Fig. 1). The
microcomputer sends a TTL pulse that enables an electronic
circuit to switch the valve from sampling to injection position.
A third opto-switch (opto R in Fig. 1) was used to generate
another TTL pulse that is necessary to return the valve to its
initial position. This last pulse is produced when the first bubble
of the monosegment passes through opto-switch R, which was
placed at a distance from the sampling valve equivalent to the
size of the monosegment. Sampling valve commutation was
found to occur in about 400 ms.
Automatic Reagent Addition Module
This device was constructed by inserting one (or more)
hypodermic syringe needles in a PTFE tube (1.6 mm id), which
was fixed with polyester resin, as shown in Fig. 2(a). This
needle was placed between two opto-switches and each needle
was connected to a three-way solenoid valve (12 V, 80 mA), as
shown in Fig. 2(b). The opto-switches can locate the air bubbles
and, therefore, the monosegment containing the sample for
reagent addition. The first opto-switch was placed before the
needle and the second one air bubble away from the needle.
When the first air bubble reaches the second sensor, the solenoid
valve is turned on and reagent is delivered into the sample
monosegment. The valve is turned off when the second air
bubble reaches the first opto-switch. The electronic circuit
necessary to perform this operation is shown in Fig. 3
The analyser was constructed with two modules that can add
up to three and up to two reagents, respectively (modules 1 and
2 in Fig. 1). The addition of the reagent can be selected and
enabled/disabled by software.
Detection System
The detection system was constructed with a flow cell, an opto-
switch and the diode array spectrophotometer.21 An opto-switch
(D) was placed after the flow cell as shown in Fig. 1, so that the
central zone of the sample monosegment is inside the flow cell
when its first bubble reaches the switch. At this moment, a logic
signal is generated, triggering the microcomputer to perform the
absorbance measurements.
Software for the Analyser
The software for instrument control, data acquisition and
treatment was written in Microsoft QuickBasic 4.5. A simpli-
fied flow chart of the computer program is shown in Fig. 4.
First, it allows start-up of the instrument, by filling the reaction
coil with the carrier fluid and the tubing of the addition modules
with reagents. The software requests from the operator the
sample identification, the number of standards (3–7) and their
respective concentrations (to construct calibration curves), the
reagents that will be delivered (up to three in the first module
and up to two in the second) and the wavelength at which the
absorbance will be measured. The spectrophotometer is con-
trolled as described elsewhere21 and the intensity signals for
three, five or nine diodes (covering about a 1.2, 1.9 and 3.5 nm
wavelength range centred around the selected wavelength) are
transferred to the microcomputer to obtain averaged absorption
signals.
Before starting analysis, the microcomputer requests a
reference spectral data set to perform absorbance calculations.
The software asks for solutions (standards or samples) neces-
sary to perform the determination. Data are processed in real
time, results (as a report, showing the calibration curve and
concentration of the samples) are shown on the microcomputer
video and stored into a file named by the operator. A hard copy
of the report can be obtained, if desired.
Reagents and Solutions
Analytical-reagent grade reagents and de-ionized water were
used to prepare all solutions.
Chromium(vi) working standard solutions from 0.200 to
1.400 mg l21 were prepared by dilution of a 1000 mg l21 CrVI
stock standard solution. A 0.25% m/v diphenylcarbazide (DPC)
solution was prepared in 25% v/v acetic acid and 2.0 mol l21
sulfuric acid solution was prepared by dilution of the concen-
trated acid.
A 0.01 mol l21 PIPES buffer solution (pH 7.2) was prepared
by 1 + 4 v/v dilution of the Merck (Darmstadt, Germany)
solution (catalogue No. 14144). Merck reactive No. 14143
(GOD–PAP method) was diluted 1 + 40 with Merck solution
No. 14144. b-d-Glucose standard solutions were prepared in the
range 0.50–10.0 mg dl21 in 0.01 mol l21 PIPES buffer
solution.
Creatinine standard solutions were prepared from 0.10 to
1.20 mg dl21 in 0.1 mol l21 hydrochloric acid and 4.0 mol l21
sodium hydroxide and 5.5 3 1022 mol l21 picric acid solutions
were prepared with de-ionized water.
Urea standard solutions were prepared from 0.50 to 5.00
mg dl21. A 0.10 mol l21 phosphate buffer (pH 7.2) was
prepared in 0.9% sodium chloride and 0.001% v/v Brij 30
solution. A 44 kU l21 urease solution was prepared in water.
Fig. 1 Schematic diagram of the automated flow analyser. For details, see text.
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Other solutions were 6.0% phenol plus 1.0% sodium nitroprus-
side and 1.0% sodium hypochlorite in 4.0 mol l21 sodium
hydroxide.
Procedures
Evaluation of the analyser
A manifold similar to that shown in Fig. 1 was employed, but
with reactor 1 removed and a PTFE tubing coil of 1.5 m length
and 1.6 mm id used as reactor 2. De-ionized water was used as
the carrier at a flow rate of 2.0 ml min21. The first and the
second air bubbles, limiting the monosegment, had volumes of
90 and 50 ml, respectively. These flow parameters allowed a
residence time of 90 s for the samples, after the second module
of reagent addition. The sample monosegment volume was
300 ml, except where specified otherwise.
Determination of glucose, creatinine and urea
The manifold shown in Fig. 1 was employed. Two glass reactors
of 1.6 mm id were used; the carrier flow rate and bubble air
volumes were kept as in the evaluation of the analyser, allowing
residence times for samples of 2.0 and 6.5 min in the first and
second reactors, respectively. The sample loop had a volume of
220 ml.
For glucose determination, blood plasma samples were
manually diluted 1 + 45 v/v with 0.01 mol l21 PIPES buffer
solution. This buffer solution was also employed as the carrier
and the reagent was delivered through the second reagent
addition module at a flow rate of 0.16 ml min21. Absorbance
measurements were carried out at 510 nm.
For creatinine determination, blood serum was deproteinized
with 5% trichloroacetic acid solution (1 + 1 v/v). The
supernatant was manually diluted 1 + 1 v/v with deionized
water. Sodium hydroxide (0.16 ml min21) and picric acid (0.28
ml min21) were added to the sample through the first and
Fig. 2 (a) Reagent addition module and (b) addition point P (stainless-
steel needle).
Fig. 3 Electronic circuit of the reagent addition module: (a) circuit to turn on and turn off the solenoid valve (enabled by the microcomputer) and (b) circuit
to extract logic signal from the opto-switch.
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second reagent addition modules, respectively. De-ionized
water was used as the carrier. Absorbance measurements were
made at 500 nm.
For urea determination, blood serum samples were dep-
roteinized as in the determination of creatinine. The supernatant
was diluted 1 + 45 v/v with phosphate buffer solution, which
was also used as the carrier. Urease solution (0.16 ml min21)
was added through the first module; phenol–sodium nitroprus-
side (0.16 ml min21) and sodium hypochlorite–sodium hydrox-
ide (0.16 ml min21) solutions were both mixed with the sample
through the second reagent addition module. Absorbance was
measured at 620 nm.
Results and Discussion
Evaluation of the Analyser
MSFA analysers usually work with several samples being
processed sequentially in the reaction coil, in order to allow for
long residence times without decreasing the sample throughput.
Therefore, one sample could be passing through the detector
(and absorbance measurement must be performed) while some
other tasks, such as switching of the sampling valve or addition
of reagent, have also to be carried out. Thus, the hardware and
software of the MSFA analyser was developed in order not to
miss an absorbance measurement. The switching of the
sampling valve from injection position to sampling position and
the addition of reagents to the sample are performed automat-
ically under hardware control enabled by the computer. The
microcomputer has the task of sending a logic signal to perform
sample injection and this action can be delayed for a few
seconds if an absorbance measurement is being obtained for a
sample present in the flow cell. Fig. 4 shows the flow diagram
of the routine that allows the control of these tasks. In addition
to releasing the microcomputer, the opto-switch, used to trigger
the return of the sampling valve to its injection position, makes
this event independent of the flow rate, which is an advantage
when a method is being developed.
A disadvantage of an MSFA analyser, in general, is related to
the admission and/or formation of small air bubbles in the
reactor, because the air bubbles of the monosegment are used to
drive reagent delivery through the addition modules and to
control sample measurement. This problem was minimised by
adjusting the opto-switch sensitivities with RC components of
the circuit shown in Fig. 3(b). For a carrier flow rate of 2.0
ml min21, the opto-switch sensitivities were adjusted in order
not to generate a logic level transition for air bubbles lower than
20 ml.
The CrVI–DPC reaction was used to evaluate the analyser
performance, by adding 2.0 mol l21 sulfuric acid and 0.25%
DPC at flow rates of 0.07 and 0.15 ml min21, respectively,
consecutively to 300 ml of sample through modules 1 and 2.The
concentrations of the reagents and the flow rate ratios between
reagents and carrier (sample) were determined according to the
standard recommended method.26 Absorbance measurements
were performed at 540 nm, with a bandwidth of 3.5 nm
(averaging signal intensities of nine diodes). Standard solutions
of CrVI from 0.2 to 1.4 mg l21 were injected in tripiclate at a
sampling frequency of 60 h21. Absorbance values were
obtained in the range 0.0611– 0.4069, with an average absolute
standard deviation of 0.0017. The precision obtained in these
absorbance measurements agrees with those obtained pre-
viously in the absence of reactions,21 indicating that the
analyser shows a very good performance. The injection of a
blank solution (water, A = 0.0016 ± 0.0016) after a 1.4 mg l21
CrVI standard solution (A = 0.4069 ± 0.0021) showed that there
is no significant carry-over between samples. The calibration
curve obtained with these data is A = (0.0078 ± 0.0028) +
(0.2880 ± 0.0031)C (r = 0.9997), where A is solution
absorbance and C is the CrVI concentration, in mg l21.
Considering that the analyser has a flow cell with only a 5 mm
long pathlength, these results also agree with those obtained
previously, with respect to sensitivity and linearity.11
The injection of 300 ml of a CrVI sample solution, as
described, resulted in a consumption of 7.5 ml of sulfuric acid
and 12 ml of the DPC solution. When 100 ml of sample were
injected, these consumptions were lowered to 2.5 and 4.0 ml,
respectively. Table 1 shows some parameters obtained under
different conditions of analysis; the sensitivity is almost
independent of the sample volume whereas the precision
(determined by the standard deviation of ten replicates of a 1.00
mg l21 CrVI solution) of the measurements decreases when the
sample volume is decreased and at higher sampling frequencies.
As can be seen, this automatic monosegmented flow analyser
shows a good performance, allowing a sensitivity that is
virtually independent of the sample volume and consuming less
reagent than other instruments because the reagents are not
delivered continuously but only into the monosegment. Fur-
Fig. 4 Flow diagram of the software developed to control sample
processing in the analyser (event 1 means solution in flow cell).
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thermore, the reagent addition module makes possible the use of
methods employing sequential reactions in MSFA, without
disturbing the monosegment pattern.
Determination of Glucose, Creatine and Urea
Standard, manually processed, methods were adapted to the
analyser in order to allow the determination of glucose,
creatinine and urea with minor changes to the manifold.
Therefore, the experimental parameters employed (mainly
sample dilution and residence time) were not optimised for each
analyte, but were aimed to suit the overall performance of the
analyser. For example, although the glucose reagent was added
through the second module, the first reactor (not necessary for
this determination) was not removed from the manifold.
However, this procedure did not alter the frequency of sample
introduction but just increased both the delay necessary for the
first sample to reach the detector and the sample dispersion to a
minor extent. It is important to emphasise that in the urea
determination, urease is added through the first module and,
after this reaction has been processed, reagents for ammonium
determination are delivered through the second reagent addition
module. This operation is the main feature of the proposed
analyser, i.e., it became possible to perform sequential reactions
without disturbing the monosegment and with reagents being
added only to the sample.
Glass reactors were used in the manifold because the sample
monosegment was not stable in PTFE reactors, mainly in the
determination of creatinine. This probably occurs because blood
proteins have a stronger affinity for PTFE. On the other hand,
glass is wet by aqueous solutions and, therefore, when this
material is employed, an increase in cross-contamination and a
decrease in precision are observed. A manifold made with PTFE
reactors allows insignificant cross-contamination and an RSD
of 0.7% for six injections of a 1.00 mg dl21 creatinine aqueous
reference solution. A signal that is 2.5% of that obtained for any
creatinine reference solution in the range 0.1–1.2 mg dl21 was
observed for the first blank introduced after the reference
solution in a glass reactor. This characterises a cross-contamina-
tion that should be considered if the introduction of samples
and/or reference solutions is not replicated. However, cross-
contamination effects were minimised by injecting samples in
triplicate and averaging the three signals obtained, because it
only affects the first signal. Furthermore, as in real calibration
and sample determinations the change in concentration is not so
drastic, the cross-contamination is minimised. This is partic-
ularly true for the samples.
Table 2 shows the figures of merit for the methodologies
adapted to the developed analyser. The results obtained with the
analyser (MSFA) were plotted against those obtained by the
Clinical Hospital (CH) of UNICAMP and the results for
glucose, creatinine and urea were MSFA = 4.72 + 0.895CH (r
= 0.997, n = 25), MSFA = 0.0785 + 1.155CH (r = 0.982,
n = 29) and MSFA = 13.5 + 0.956CH (r = 0.996, n = 17),
respectively. At the Clinical Hospital, the determinations were
performed by automatic discrete analysers, i.e., Merck–Vitalab
Selectra (glucose) and Roche Cobas–Mira (creatinine and urea).
Glucose and creatinine were also determined by the GOD–PAP
and Jaffé methods, respectively. However, a kinetic procedure
was employed in both determinations and the results were
obtained from the difference between two absorbance measure-
ments, made in a pre-defined time interval. Urea determination
was based on the reaction of ammonium ion (produced by
urease catalysed urea hydrolysis) with 2-oxoglutarate and
NADH, in the presence of glutarate dehydrogenase, and the
decrease in absorbance, due to the NADH consumed, was
measured at 340 nm. Although a good correlation coefficient
was always observed (r > 0.98) for the three analytes, the
results do not agree completely and there are both constant and
proportional systematic differences. The origin of these differ-
ences can be attributed to the different methodologies and/or
instruments employed, as pointed out by Koch and Peters.27 For
example, in the creatinine determination some interferences
(e.g., from proteins) can be eliminated by employing a kinetic
method, as in the procedure used in the Clinical Hospital.
Differences such as those found in this work have often been
reported for clinical methodologies28–35 and seem to be
tolerated from the clinical point of view. According to this point
of view, these differences are not a serious drawback to the use
of the proposed methodologies because the range of reference
values for blood analyte concentrations is a function of the
methodology and/or instrument employed for the determina-
tion.27
Conclusions
The automated analyser allows determinations to be performed
with low reagent consumption. Furthermore, with the develop-
ment of the reagent addition modules it is possible to adapt
methods based on sequential reactions to MSFA without
disturbing the monosegment, because the reagents are delivered
only into the sample zone. Direct adaptation of the manual
procedures can be made by setting appropriate flow rates for
carrier fluid and reagents, which maintain the proportion of the
manual procedures. The sensitivity of the analyser shows little
dependence on the carrier flow rate if the reagent flow rate is
kept proportional and the reaction reaches completion. Also, the
sensitivity is almost independent of the sample volume, owing
to low monosegment dispersion and proportional addition of
reagents. Finally, the same manifold can be used to determine
different analytes, although some straightforward dilution
Table 1 Dependence of the sensitivity and precision of the monosegmented flow analyser on sample volume and sample frequency
Calibration curve
Vsample/ Frequency/ Linear A ± s*
ml h21 coefficient Slope r (n = 10)
300 60 0.0027 0.2459 0.9996 0.2519 ± 0.0016
100 60 0.0020 0.2376 0.9999 0.2337 ± 0.0031
100 120 0.0029 0.2306 0.9996 0.2341 ± 0.0051
* Absorbance of a 1.00 mg l21 CrVI reference solution ± standard deviation.
Table 2 Figures of merit for glucose, creatinine and urea determination with
the monosegmented flow analyser
Averaged Upper limit of
precision linear range/




* Before sample dilution, as described under Experimental.
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operations need to be performed before sample introduction into
the system.
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